Drug interactions
Alogliptin-pioglitazone + Selexipag
Severity: Minor
Alogliptin-pioglitazone and Selexipag: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Selexipag is converted to its active metabolite partly via CYP2C8, and strong inhibitors markedly raise exposure.
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to see why Alogliptin-pioglitazone and Selexipag interact, what to do about it, and the sources.
- Mechanism of action
- Clinical management
- Evidence level
Free 14-day trial. No card needed.
Other interactions of Alogliptin-pioglitazone
Other interactions of Selexipag
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
